IA
CORT icon

IFP Advisors’s Corcept Therapeutics CORT Stock Holding History

IFP Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Buy
909
+773
+568% +$46.7K ﹤0.01% 2129
2026
Q1 		$5.48K Sell
136
-52
-28% -$1.94K ﹤0.01% 3462
2025
Q4 		$6.54K Sell
188
-154
-45% -$12.1K ﹤0.01% 3279
2025
Q3 		$28.4K Sell
342
-84
-20% -$6.08K ﹤0.01% 2390
2025
Q2 		$31.3K Sell
426
-312
-42% -$22.6K ﹤0.01% 2298
2025
Q1 		$84.3K Buy
738
+679
+1,151% +$41.3K ﹤0.01% 1623
2024
Q4 		$2.97K Buy
59
+11
+23% +$576 ﹤0.01% 2965
2024
Q3 		$2.22K Hold
48
– – ﹤0.01% 2891
2024
Q2 		$1.56K Buy
+48
New +$1.31K ﹤0.01% 2878
2023
Q1 		– Sell
-3,645
Closed -$82K – 3567
2022
Q4 		$82K Sell
3,645
-125
-3% -$3.13K ﹤0.01% 1873
2022
Q3 		$84K Buy
3,770
+64
+2% +$1.71K ﹤0.01% 1982
2022
Q2 		$84K Hold
3,706
– – ﹤0.01% 1807
2022
Q1 		$84K Buy
3,706
+2,453
+196% +$52.2K ﹤0.01% 1807
2021
Q4 		$27K Buy
1,253
+100
+9% +$2.03K ﹤0.01% 1810
2021
Q3 		$25K Buy
1,153
+997
+639% +$20.9K ﹤0.01% 1882
2021
Q2 		$4K Buy
+156
New +$3.47K ﹤0.01% 2536
2019
Q1 		– Sell
-275
Closed -$4K – 2541
2018
Q4 		$4K Sell
275
-601
-69% -$7.94K ﹤0.01% 2917
2018
Q3 		$12K Buy
876
+554
+172% +$7.74K ﹤0.01% 2731
2018
Q2 		$5K Buy
+322
New +$5.6K ﹤0.01% 3233

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's CORT Position: Q2 2026 in Review

IFP Advisors increased its Corcept Therapeutics (CORT) stake by 568% in Q2 2026, buying an estimated $46.7K and bringing the position to 909 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

IFP Advisors first reported a position in CORT in Q2 2018 and has held it in 19 quarters since. The position peaked at $84.3K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • IFP Advisors held 909 shares of Corcept Therapeutics worth $79K as of Q2 2026.
  • IFP Advisors bought 773 Corcept Therapeutics shares in Q2 2026, an estimated $46.7K.
  • Corcept Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2129 holding.
  • IFP Advisors first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 19 quarters since.
  • IFP Advisors's Corcept Therapeutics position peaked at $84.3K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.